drug

avapritinib

1 story · latest Aug 10, 2026

Status: FDA approved Jan 2020 · NDA212608
Brand: Ayvakit

Timeline

Cogent Biosciences reports Q2 2026 results, two bezuclastinib PDUFA dates ahead

Aug 10Quarterly updatebezuclastinib Cogent Biosciences, Inc.

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.